Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia

McAllister, Florencia, Bailey, Jennifer M., Alsina, Janivette, Nirschl, Christopher J., Sharma, Rajni, Fan, Hongni, Rattigan, Yanique, Roeser, Jeffrey C. +10 more·2014·Cancer Cell

Cited by (404)

Items 101–200 of 404

  1. γδ T cells in cancer: a small population of lymphocytes with big implications
    Mathilde Raverdeau, Stephen Cunningham, Cathal Harmon, Lydia Lynch · 2019 · Clinical & Translational Immunology
  2. IL-17A-producing CD8 + T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts
    Felix S.R. Picard, Veronika Lutz, Anna I. Brichkina, Felix Neuhaus, Teresa Ruckenbrod, Anna Hupfer, Hartmann Raifer, Matthias Klein, Tobias Bopp, Petra Ina Pfefferle et al. · 2023 · Gut
  3. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment
    Kelly J. Lafaro, Laleh Golkar Melstrom · 2018 · American Journal Of Pathology
  4. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
    Xiaomeng Liu, Jin Xu, Bo Zhang, Jiang Liu, Chen Liang, Qingcai Meng, Jie Hua, Xianjun Yu, Si Shi · 2019 · Molecular Cancer
  5. Interleukin 22 signaling regulates acinar cell plasticity to promote pancreatic tumor development in mice
    Perusina Lanfranca, Mirna, Zhang, Yaqing, Girgis, Alexander, Kasselman, Samantha, Lazarus, Jenny, Kryczek, Illona, Delrosario, Lawrence, Rhim, Andrew, Koneva, Lada, Sartor, Maureen et al. · 2020 · Gastroenterology
  6. Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma
    Rocky Barilla, Brian E. Diskin, Raul Caso Caso, Ki Buom Lee, Navyatha Mohan, Chandan Buttar, Salma Adam, Zennur Sekendiz, Junjie Wang, Ruben D. Salas et al. · 2019 · Nature Communications
  7. IL-17 Suppresses Immune Effector Functions in Human Papillomavirus-Associated Epithelial Hyperplasia
    Christina Gosmann, Stephen R. Mattarollo, Jennifer Anne Bridge, Ian Hector Frazer, Antje Blumenthal · 2014 · The Journal of Immunology
  8. Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer
    Emelie Foord, Lucas C. M. Arruda, Ahmed Gaballa, Charlotte Klynning, Michael Uhlin · 2021 · Science Translational Medicine
  9. Elimination of oncogenic Kras in genetic mouse models eradicates pancreatic cancer by inducing Fas-dependent apoptosis by CD8+ T cells
    K. Mahadevan, V. LeBleu, E. V. Ramirez, Yang Chen, Bing-Rui Li, Amari M. Sockwell, M. Gagea, H. Sugimoto, Lakshmi Kavitha Sthanam, D. Tampe et al. · 2023 · Developmental Cell
  10. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
    Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, Laura Soucek · 2024 · Signal Transduction and Targeted Therapy
  11. Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
    Stalin Chellappa, Harald Hugenschmidt, Morten Hagness, Pål‐Dag Line, Knut Jørgen Labori, Gro Wiedswang, Kjetil Taskén, Einar Martin Aandahl · 2015 · OncoImmunology
  12. Targeting Th17‐IL‐17 Pathway in Prevention of Micro‐Invasive Prostate Cancer in a Mouse Model
    Qiuyang Zhang, Sen Liu, Dongxia Ge, David M. Cunningham, Feng Huang, Lin Ma, Thomas P. Burris, Zongbing You · 2017 · The Prostate
  13. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications
    Robin John Lester Imperial, Omer M. Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood · 2017 · Seminars in Cancer Biology
  14. Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic
    Emmanouil Fokas, Eric O’Neill, Alex Nicolas Gordon-Weeks, Somnath Mukherjee, W. Gillies McKenna, Ruth J. Muschel · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  15. The pancreatic cancer microenvironment: A true double agent
    Laleh Golkar Melstrom, Marcela d'Alincourt Salazar, Don J. Diamond · 2017 · Journal of Surgical Oncology
  16. Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer
    Susanne Roth, Katharina Zamzow, Matthias M. Gaida, Mathias F Heikenwälder, Christine Tjaden, Ulf Hinz, Promita Bose, Christoph W. Michalski, Thilo Hackert · 2020 · EBioMedicine
  17. Macrophages and T cells in metabolic disorder-associated cancers
    Daniel Taranto, D. Kloosterman, L. Akkari · 2024 · Nature Reviews. Cancer
  18. A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas
    David J. Falvo, Adrien Grimont, Paul Zumbo, William B. Fall, Julie L. Yang, Alexa Osterhoudt, Grace Pan, André F. Rendeiro, Yinuo Meng, John Erby Wilkinson et al. · 2023 · Developmental Cell
  19. The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
    Maruhen Amir Datsch Silveira, Steve Bilodeau, Tim F. Greten, Xin Wei Wang, Giorgio Trinchieri · 2022 · Trends in cancer
  20. The tumor-intrinsic role of the m 6 A reader YTHDF2 in regulating immune evasion
    Sai Xiao, Shoubao Ma, Baofa Sun, Wenchen Pu, Songqi Duan, Jingjing Han, Hong Ya-qun, Jianying Zhang, Yong Peng, Chuan He et al. · 2024 · Science Immunology
  21. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
    Muhammad Shamsul Alam, Matthias M. Gaida, Frank Bergmann, Felix Lasitschka, Thomas Giese, Nathalia A. Giese, Thilo Hackert, Ulf Hinz, S. Perwez Hussain, С. В. Козлов et al. · 2015 · Nature Medicine
  22. Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
    Robert Hester, Pawel Karol Mazur, Florencia McAllister · 2021 · Clinical Cancer Research
  23. WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer
    Wenting Du, Rosa Elena Menjivar, Katelyn L. Donahue, Padma Kadiyala, Ashley Velez-Delgado, Kristee L. Brown, Hannah R. Watkoske, Xi He, Eileen S. Carpenter, Christina Vadala Angeles et al. · 2022 · The Journal of Experimental Medicine
  24. Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer
    Krishnan K. Mahadevan, Allison M. Dyevoich, Yang Chen, Bingrui Li, Hikaru Sugimoto, Amari M. Sockwell, Kathleen M. McAndrews, Lakshmi Kavitha Sthanam, Huamin Wang, Shabnam Shalapour et al. · 2024 · Science
  25. Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation
    Vidhi Chandra, Le Li, Olivereen Le Roux, Yu Zhang, Rian M. Howell, Dhwani N. Rupani, Seyda Baydogan, Haiyan D Miller, Erick Marcelo Riquelme, Joseph F. Petrosino et al. · 2023 · Cancer Cell
  26. IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells
    Yuanyan Wei, Danfang Shi, Ziwei Liang, Yuming Liu, Yinan Li, Yang Xing, Weitao Liu, Zhilong Ai, Jianhui Zhuang, Xiaoning Chen et al. · 2019 · Journal of Hepatology
  27. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
    Cameron J. Herting, Isaac Karpovsky, Gregory B. Lesinski · 2021 · Cancer and Metastasis Reviews
  28. BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
    Audrey Benyamine, Céline Loncle, Etienne D. Foucher, Juan-Luis Blazquez, Céline Castanier, Anne-Sophie Chrétien, Mauro Modesti, Véronique Secq, Salem Chouaı̈b, Meritxell Gironella et al. · 2017 · OncoImmunology
  29. Immunity beyond cancer cells: perspective from tumor tissue
    Shengyu Gao, Ting-Wei Hsu, Ming O. Li · 2021 · Trends in cancer
  30. Neutrophil in the Pancreatic Tumor Microenvironment
    Lin Jin, Hong Sun Kim, Jiaqi Shi · 2021 · Biomolecules
  31. Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer
    Matteo Bellone, Arianna Brevi, Samuel Huber · 2020 · Microbiology and Molecular Biology Reviews
  32. Uncertain Beginnings: Acinar and Ductal Cell Plasticity in the Development of Pancreatic Cancer
    Adrien Grimont, Steven D. Leach, Rohit Chandwani · 2021 · Cellular and Molecular Gastroenterology and Hepatology
  33. Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desert
    Xiaoqi Li, Mansi Gulati, Alaina C. Larson, Joyce C. Solheim, Maneesh Jain, Sushil Kumar K, Surinder K. Batra · 2022 · Seminars in Cancer Biology
  34. Regulation of EMT by STAT3 in gastrointestinal cancer (Review)
    Bo Li, Chen Huang · 2017 · International Journal of Oncology
  35. Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
    Jieti Wang, Chao Lin, He Li, Ruochen Li, Yifan Wu, Hao Liu, Heng Zhang, Hongyong He, Weijuan Zhang, Jiejie Xu · 2017 · OncoImmunology
  36. An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma
    Danielle Woodford · 2014 · Journal of Clinical & Cellular Immunology
  37. Pancreatic cancer microenvironment, to target or not to target?
    Ryan Michael Carr, Martín E. Fernández-Zapico · 2016 · EMBO Molecular Medicine
  38. IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions
    Gianluca Mucciolo, Claudia Curcio, Cecilia Roux, Wanda Y. Li, Michela Capello, Roberta Curto, Roberto Chiarle, Daniele Giordano, Maria Antonietta Satolli, Rita Teresa Lawlor et al. · 2021 · Proceedings of the National Academy of Sciences
  39. Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises
    Lin Mei, Wei Du, Wen Wee Ma · 2016 · Journal of Gastrointestinal Oncology
  40. A genetic roadmap of pancreatic cancer: still evolving
    Faiyaz Notta, Stephan A. Hahn, Francisco X. Real · 2017 · Gut
  41. Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
    Zoe C. Schmiechen, Ingunn M. Stromnes · 2021 · Frontiers in Immunology
  42. Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment
    Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, Xiaoqi Li, Surinder K. Batra, Sushil Kumar K · 2022 · Seminars in Cancer Biology
  43. Emerging strategies for cancer immunoprevention
    Jeffrey C. Roeser, Steven D. Leach, Fiona Elizabeth McAllister · 2015 · Oncogene
  44. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation
    Daniel Hsu, Patricia R. Taylor, Dave Fletcher, Rolf Van Heeckeren, Jean F. Eastman, Anna M. van Heeckeren, Pamela B. Davis, James Francis Chmiel, Eric M. Pearlman, Tracey L. Bonfield · 2016 · Infection and Immunity
  45. Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance
    Shigeru Hashimoto, Ari Hashimoto, Ryuta Muromoto, Yuichi Kitai, Kenji Oritani, Tadashi Matsuda · 2022 · Cells
  46. Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
    Thomas Yul Avery, Natalie Köhler, Robert Zeiser, Tilman Brummer, Dietrich Alexander Ruess · 2022 · Frontiers in Oncology
  47. TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL-1β+ Macrophages
    Daowei Yang, Xinlei Sun, Hua Wang, Ignacio Ivan Wistuba, Huamin Wang, Anirban Maitra, Yang Chen · 2025 · Gastroenterology
  48. Gamma delta (γδ) T cells in cancer immunotherapy; where it comes from, where it will go?
    Jiechu Deng, Hong-Na Yin · 2022 · European Journal of Pharmacology
  49. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
    Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro, Gabriella Mincione · 2023 · Cancers
  50. The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment
    Yuanyuan Pan, Wenjing Yang, Bo Tang, Xiaobo Wang, Qi Zhang, Weiping Li, Li Li · 2023 · Frontiers in Immunology
  51. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer
    Sushil Kumar K, Srustidhar Das, Satyanarayana Rachagani, Sukhwinder Kaur, S Joshi, Sonny L. Johansson, Moorthy Palanimuthu Ponnusamy, Maneesh Jain, Surinder K. Batra · 2014 · Oncogene
  52. Epithelial-Stromal Interactions in Pancreatic Cancer
    Yaqing Zhang, Howard C. Crawford, Marina Pasca di Magliano · 2018 · Annual Review of Physiology
  53. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
    Qi Zhou, Xufeng Tao, Shilin Xia, Fangyue Guo, Pan Chen, Hong Xiang, Dong Shang · 2020 · Frontiers in Oncology
  54. Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response?
    Mwila Kabwe, Stuart G. Dashper, Gilad Bachrach, Joseph Tucci · 2021 · FEMS Microbiology Reviews
  55. NLRP3 inflammasome-induced pyroptosis in digestive system tumors
    Jiexia Wen, Bin Xuan, Yang Liu, Liwei Wang, Li He, Xiangcai Meng, Tao Zhou, Yimin Wang · 2023 · Frontiers in Immunology
  56. Cancer risk in patients with psoriasis: should we be paying more attention?
    Nikolai Loft, Sofie Vaengebjerg, Lone Skov · 2020 · Expert Review of Clinical Immunology
  57. Prolactin promotes fibrosis and pancreatic cancer progression
    Manuj Tandon, Gina M. Coudriet, Angela Criscimanna, Mairobys Socorro, M. Eliliwi, A. Singhi, Z. Cruz-Monserrate, P. Bailey, M. Lotze, H. Zeh et al. · 2019 · Cancer Research
  58. Immunocytes in the tumor microenvironment: recent updates and interconnections
    Jiyao Yu, Li Fu, Rui Wu, Linyi Che, Guodong Liu, Qinwen Ran, Zhiwei Xia, Xisong Liang, Guanjian Zhao · 2025 · Frontiers in Immunology
  59. Molecular Pathways: Myeloid Complicity in Cancer
    Ingunn M. Stromnes, Philip D. Greenberg, Sunil R. Hingorani · 2014 · Clinical Cancer Research
  60. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies
    Afsane Bahrami, Majid Khazaei, Fariba Bagherieh, Majid Ghayour‐Mobarhan, Mina Maftouh, Seyed Mahdi Hassanian, Amir Avan · 2017 · Journal of Cellular Physiology
  61. Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo
    Amanda R. Wasylishen, Chang Sun, Sydney M. Moyer, Yuan Qi, Gilda P. Chau, Neeraj K. Aryal, Florencia M. McAllister, Michael P. Kim, Michelle Craig Barton, Jeannelyn Santiano Estrella et al. · 2020 · Science Advances
  62. The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
    Group Young Researchers in Inflammatory Carcinogenesis, Anna Maxi Wandmacher, Anne‐Sophie Mehdorn, Susanne Sebens · 2021 · Cancers
  63. An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer
    Jinglong Guo, Siyue Wang, Qi Gao · 2023 · Frontiers in Immunology
  64. Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
    Yunbo He, Jinliang Huang, Qiaorong Li, Weiping Xia, Chunyu Zhang, Zhi Liu, Jiatong Xiao, Zhenglin Yi, Hao Deng, Zicheng Xiao et al. · 2022 · Cancers
  65. Interleukin-17 Promotes Migration and Invasion of Human Cancer Cells Through Upregulation of MTA1 Expression
    Na Guo, Ge Shen, Ying Zhang, Ahmed A. Moustafa, Dongxia Ge, Zongbing You · 2019 · Frontiers in Oncology
  66. Unraveling the gut microbiome’s contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives
    Eileen Tabrizi, Fatemeh Pourteymour Fard Tabrizi, Gehad Mahmoud Khaled, Michael P. Sestito, Saeid Jamie, Brian A. Boone · 2024 · Frontiers in Immunology
  67. Promotion of lung tumor growth by interleukin-17
    Beibei Xu, James F. Guenther, Derek A. Pociask, Yu Wang, Jay K. Kolls, Zongbing You, Bysani Chandrasekar, Bin Shan, Deborah E. Sullivan, Gilbert F. Morris · 2014 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  68. Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked
    Gérard I. Evan, Nasun Hah, Trevor D. Littlewood, Nicole M. Sodir, Tania Campos, Michael Downes, Ronald M. Evans · 2017 · Clinical Cancer Research
  69. p120 Catenin suppresses basal epithelial cell extrusion in invasive pancreatic neoplasia
    Audrey M. Hendley, Y. Wang, Kishore Polireddy, Janivette Alsina, Ishrat Ahmed, Kelly J. Lafaro, Hao Zhang, Nilotpal Roy, Samuel G. Savidge, Yan-Na Cao et al. · 2016 · Cancer Research
  70. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials
    Mingjie Jiang, Juanjuan Dai, Dian-na Gu, Qian Huang, Ling Tian · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  71. Advance investigation on synthetic small-molecule inhibitors targeting PD-1/PD-L1 signaling pathway
    Annoor Awadasseid, Yanling Wu, Wen Zhang · 2021 · Life Sciences
  72. Unstable Foxp3+ Regulatory T Cells and Altered Dendritic Cells Are Associated with Lipopolysaccharide-Induced Fetal Loss in Pregnant Interleukin 10-Deficient Mice1
    Jelmer Riemer Prins, Bihong Zhang, John Even Schjenken, Leigh R. Guerin, Simon Charles Barry, Sarah Anne Robertson · 2015 · Biology of Reproduction
  73. Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor
    Sen Liu, Qiuyang Zhang, Chong Chen, Dongxia Ge, Yine Qu, Rongyi Chen, Yi-Ming Fan, Nan Li, Wendell W. Tang, Wensheng Zhang et al. · 2016 · Oncotarget
  74. Local and Systemic Expression of Immunomodulatory Factors in Chronic Pancreatitis
    Hannah M. Komar, Phil A. Hart, Zobeida Cruz‐Monserrate, Darwin L. Conwell, Gregory B. Lesinski · 2017 · Pancreas
  75. KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy
    Pinto Rosamaria, Daniela Petriella, Rosanna Lacalamita, Michele Montrone, Annamaria Catino, Pamela Pizzutilo, Botticella Maria Antonietta, Alfredo Francesco Zito, G. Del Bene, Antonia Zonno et al. · 2019 · Cancers
  76. Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome
    Bocchini, Claire E., Nahmod, Karen, Katsonis, Panagiotis, Kim, Sang, Kasembeli, Moses M., Freeman, Alexandra, Lichtarge, Olivier, Makedonas, George, Tweardy, David J. · 2016 · Blood
  77. Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
    Daniel Delitto, Shannon Margaret Wallet, Steven J. Hughes · 2016 · Pharmacology & Therapeutics
  78. CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
    Stalin Chellappa, Harald Hugenschmidt, Morten Hagness, Saranya Subramani, Espen Melum, Pål‐Dag Line, Knut Jørgen Labori, Gro Wiedswang, Kjetil Taskén, Einar Martin Aandahl · 2017 · The Journal of Immunology
  79. Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope
    Chi Li, Howard Donninger, John W. Eaton, Kavitha Yaddanapudi · 2020 · Frontiers in Immunology
  80. Alterations of commensal microbiota are associated with pancreatic cancer
    Tian Chen, Xuejiao Li, Gaoming Li, Yun Liu, Xiaochun Huang, Wei Ma, Chao Qian, Guo Jie, Shuo Wang, Qin Qin et al. · 2023 · The International Journal of Biological Markers
  81. The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer
    Sarah McCuaig, David Barras, Elizabeth H. Mann, Matthias Friedrich, Samuel J. Bullers, Alina Janney, Lucy C. Garner, Enric Domingo, Viktor Hendrik Koelzer, Mauro Delorenzi et al. · 2020 · Clinical Cancer Research
  82. Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment
    Huey-Jen L. Lin, Jiayuh Lin · 2017 · Cancers
  83. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
    Verena Hofschröer, Karolina Najder, Micol Rugi, Rayhana Bouazzi, Marco Cozzolino, Annarosa Arcangeli, György Panyi, Albrecht Schwab · 2021 · Frontiers in Pharmacology
  84. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
    Friederike V. Opitz, Lena Häberle, Alexandra Daum, Iréne Esposito · 2021 · Cancers
  85. Longitudinal Study of DNA Methylation of Inflammatory Genes and Cancer Risk
    Brian Thomas Joyce, Tao Gao, Lei Liu, Yinan Zheng, Siran Liu, Wei Zhang, Frank J. Penedo, Qi Dai, Joel David Schwartz, Andrea Baccarelli et al. · 2015 · Cancer Epidemiology Biomarkers & Prevention
  86. Development of an autophagy-related signature in pancreatic adenocarcinoma
    Peipei Yue, Chen Zhu, Yaxian Gao, Yan Li, Qi Wang, Kexin Zhang, Shuting Gao, Yaxing Shi, Yanju Wu, Biao Wang et al. · 2020 · Biomedicine & Pharmacotherapy
  87. Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer
    Heng‐Hsiung Wu, Lung‐Hung Tsai, Chun-Kai Huang, Pang‐Hung Hsu, Mei‐Yu Chen, Y.M. Chen, Chun‐Mei Hu, Chia‐Ning Shen, Chen‐Chen Lee, Ming‐Chu Chang et al. · 2021 · Science Translational Medicine
  88. Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment
    Daniel Delitto, Andrea E. Delitto, Bayli B. DiVita, Kien Pham, Song Han, Emily R. Hartlage, Brittney N. Newby, Michael H. Gerber, K.E. Behrns, Lyle L. Moldawer et al. · 2016 · Cancer Research
  89. Immune vulnerabilities of mutant KRAS in pancreatic cancer
    Noah C. Cheng, Robert H. Vonderheide · 2023 · Trends in cancer
  90. Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
    Dea Filippini, Sabrina L. D’Agosto, Pietro Delfino, Michele Simbolo, Geny Piro, Borislav Chavdarov Rusev, Lisa Veghini, Cinzia Cantù, Francesca Lupo, Stefano Ugel et al. · 2019 · Scientific Reports
  91. IL-17A contributes skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Linjung Ying, Yi-Nan Yao, Handi Lv, Guo-Hua Lu, Qin Zhang, Yun-Mei Yang, Jian-Ying Zhou · 2022 · American Journal of Physiology - Cell Physiology
  92. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
    Junliang Chen, Zhihao Liu, Z. Wu, Wenjun Li, Xiaodong Tan · 2023 · Frontiers in Oncology
  93. γδT Cells and Related Diseases
    Lu Han, Da‐Jin Li, Liping Jin · 2016 · American Journal of Reproductive Immunology
  94. The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors
    Omar Abed Alkharabsheh, M Hasib Sidiqi, Mohammed A. Aljama, Morie Abraham Gertz, Arthur Edward Frankel · 2019 · Acta Haematologica
  95. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment
    Shuangshuang Lu, Tasqeen Ahmed, Pan Du, Yaohe Wang · 2017 · International Journal of Molecular Sciences
  96. Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
    Mautin Barry-Hundeyin, Emma Kurz, Ankita Mishra, Juan Andres Kochen Rossi, Shannon M. Liudahl, Kenna R. Leis, Harshita Mehrotra, Mirhee Kim, Luisana E. Torres, Adesola Ogunsakin et al. · 2019 · Cancer Discovery
  97. A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer
    Joyce Yongxu Huang, Lesley M. Butler, Øivind Midttun, Arve Ulvik, Renwei Wang, Aizhen Jin, Yu‐Tang Gao, Per Magne Ueland, Woon‐Puay Koh, Jian‐Min Yuan · 2018 · PLoS ONE
  98. Ductal metaplasia in pancreas.
    Shu Li, K. Xie · 2022 · Biochimica et biophysica acta. Reviews on cancer
  99. Interleukin-17D promotes lung cancer progression by inducing tumor-associated macrophage infiltration via the p38 MAPK signaling pathway
    Zhenzhen Lin, Qiumin Huang, Junrong Liu, Hao Wang, Xuexi Zhang, Zhiyan Zhu, Wei Zhang, Yi‐Liang Wei, Zhe Liu, Wei Du · 2022 · Aging
  100. Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer
    Constantinos Pantelis Zambirinis, George Miller · 2017 · Trends in Molecular Medicine